Search - tctmd.com

Displaying 101 - 120 of 358

Sort: Relevancy | Date

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Conference News AHA 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

Shelley Wood

November 14, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

News Conference News TCT 2021

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Yael L. Maxwell

October 22, 2021

News Conference News TCT 2021

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

Yael L. Maxwell

October 15, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

Caitlin E. Cox

September 30, 2021

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Daily News

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

Caitlin E. Cox

August 20, 2021

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Michael O'Riordan

August 17, 2021

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

L.A. McKeown

August 16, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News ACC 2021

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

Todd Neale

May 17, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes

Todd Neale

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

Advertisement

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

No Harm From Thrombolytics in SCAD Patients With STEMI

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content